|
Title
|
|
|
|
Molecular preadaptation to antimony resistance in Leishmania donovani on the Indian subcontinent
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Antimonials (Sb) were used for decades for chemotherapy of visceral leishmaniasis (VL). Now abandoned in the Indian subcontinent (ISC) because of Leishmania donovani resistance, this drug offers a unique model for understanding drug resistance dynamics. In a previous phylogenomic study, we found two distinct populations of L. donovani: the core group (CG) in the Gangetic plains and ISC1 in the Nepalese highlands. Sb resistance was only encountered within the CG, and a series of potential markers were identified. Here, we analyzed the development of resistance to trivalent antimonials (SbIII) upon experimental selection in ISC1 and CG strains. We observed that (i) baseline SbIII susceptibility of parasites was higher in ISC1 than in the CG, (ii) time to SbIII resistance was higher for ISC1 parasites than for CG strains, and (iii) untargeted genomic and metabolomic analyses revealed molecular changes along the selection process: these were more numerous in ISC1 than in the CG. Altogether these observations led to the hypothesis that CG parasites are preadapted to SbIII resistance. This hypothesis was experimentally confirmed by showing that only wild-type CG strains could survive a direct exposure to the maximal concentration of SbIII. The main driver of this preadaptation was shown to be MRPA, a gene involved in SbIII sequestration and amplified in an intrachromosomal amplicon in all CG strains characterized so far. This amplicon emerged around 1850 in the CG, well before the implementation of antimonials for VL chemotherapy, and we discuss here several hypotheses of selective pressure that could have accompanied its emergence. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
mSphere / American Society for Microbiology. - Washington D.C., 2016, currens
mSphere / American Society for Microbiology. - Washington D.C., 2016, currens
| |
|
Publication
|
|
|
|
Washington D.C.
:
2018
| |
|
ISSN
|
|
|
|
2379-5042
| |
|
Volume/pages
|
|
|
|
3
:2
(2018)
, 17 p.
| |
|
Article Reference
|
|
|
|
e00548-17
| |
|
ISI
|
|
|
|
000430907900013
| |
|
Pubmed ID
|
|
|
|
29669889
| |
|
Medium
|
|
|
|
E-only publicatie
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|